1884 physician’s “trip report” reads like an early psychedelic bestseller

A doctor writes himself into the record

Frank Dudley Beane, a New York physician who published only a handful of papers, left behind one unforgettable account: “An Experience with Cannabis Indica,” published in the Buffalo Medical and Surgical Journal (vol. 23, 1883–84). The National Library of Medicine lists just seven journal articles under his name, but this one secured him a place in the weird little canon of drug literature — think Humphry Davy with nitrous oxide, or Albert Hofmann and his bicycle ride. Read straight through, it feels like a Victorian-era trip report that would sit comfortably on Erowid next to modern psychonautics.

From tincture to terror to lilac light

Beane, suffering “general neurasthenia,” avoided opiates and tried tinctures of cannabis and ergot sent by Parke Davis. At about 10:15 he took 0.46 ml of the cannabis tincture and 1.39 ml of ergot. What followed was a rapid, terrifying descent: dizziness, “peculiar lightness,” creeping dread, and “general muscle weakness.” He drank port, staggered upstairs “with great difficulty,” asked for brandy, and then experienced a “horrible feeling of impending death.” An attending doctor recommended atropine; the pulse was “quick and feeble.” Then came paralysis, an out‑of‑body perspective over his own corpse, and racing through a dark tunnel that opened into “the most beautiful and soft lilac shade of misty brightness.” He later described his body as feeling “fashioned from wood,” awoke hours later in hysterical delight and confusion, utterly aware yet unable to control himself.

Medicine and marketing, hand in hand?

Beane closes his account with praise for “Parke Davis & Co’s preparation of haschisch,” calling it an “exhilirant.” It has been reported that scholars suspect this praise may not be purely clinical — that Beane may have been in the pay of Parke Davis, a company known for aggressive promotion. It has been reported that Parke Davis was moving fast in the U.S. pharmaceutical boom; it has also been reported that, a year later, Sigmund Freud received payment from the company to promote cocaine. Allegedly, money and medicine have always been awkward bedfellows.

Why the old tale still matters

This isn’t just a curious footnote to drug history. Beane’s narrative gives us a rare, candid physician-as-subject account that blurs clinical observation, personal terror, and commercial spin. It asks uncomfortable questions: when doctors self-experiment, where does objective reporting end and spectacle begin? And in an era where pharma PR still shapes medical narratives, that question feels surprisingly modern. Who knew a 19th‑century doctor’s lilac light would still make us squint?

Sources: publicdomainreview.org, Hacker News